Medicare Compliance & Reimbursement
DRUGMAKERS SADDLED WITH PRICE-CHANGE LIMITS
There's good news and bad news for drugmakers in new rules on Medicaid rebates. Drugmakers will soon be subject to a three-year time limit for submitting drug pricing changes under the Medicaid rebate program. That's the upshot of a final rule the Centers for Medicare & Medicaid Services released Aug. 29. The rule - which finalizes two provisions of a proposal that's been on the books since 1995 - aims to set up procedural requirements relating to drugmakers' recordkeeping and pricing activities. The procedural changes are designed to ease the administrative burden on state Medicaid agencies. The bad news for drugmakers is the price change limit, which essentially narrows their window of opportunity for submitting pricing changes. The good news, potentially, is a second provision of the rule that requires drugmakers to preserve data on pricing and rebates for a period of three years - as opposed to the apparently indefinite record retention period that currently applies. The only exception to the three-year limit involves instances when drug manufacturers are being audited or investigated by the feds. The rule goes into effect Oct. 1, 2003. To see the rule, go to http://www.access.gpo.gov/su_docs/fedreg/a030829c.html. Lesson Learned: After years of waiting, drugmakers finally have clear guidance on their record retention obligations under the Medicaid drug rebate program.
Medicare Compliance & Reimbursement
- Rehab:
RELIEF IN SIGHT ON 75-PERCENT RULE
How does a 65-percent rule sound?
Struggling inpatient rehabilitation facilities may be able to qualify for [...] - Medicare Reform:
MEDICARE REFORM CONFEREES BICKER AS NEGOTIATIONS CONTINUE
House and Senate Medicare negotiators are meeting this week to vote on tentative agreements reached [...] - Medicare Reform:
DRUG BILL'S E-PROVISIONS are the wRONG PRESCRIPTION, SAY DOCS
Congress should make electronic prescription voluntary, not mandatory, under Medicare prescription-drug legislation it's developing, a [...] - HOSPITAL FACES EXCLUSIONFROM MEDICARE
OIG pursues "death penalty" against Tenet facility. Exclusion from Medicare: It's one of the harshest [...] - Compliance Watch:
GRANT RECIPIENTS NEXT IN LINE FOR COMPLIANCE GUIDANCE
OIG considers adding eighth core compliance element to existing seven.
Compliance program guidance (CPG) currently in [...] - Home Health:
HHAs Caught In The Middle On Supplies Bundling
Home health agencies' failure to report medical supply costs under the prospective payment system could [...] - Emergency Medicine:
EMTALA RULE REDUCES OFF-CAMPUS OBLIGATIONS
Under a final rule scheduled for Sept. 9 publication by the Centers for Medicare and [...] - Pharmaceuticals:
4 SOLUTIONS TO THE OUTPATIENT DRUG PUZZLE
A new world is at hand for Medicare drug payments.
Responding to what the feds worry [...] - Managed Care:
PENALTIES INCREASE FOR M+COs
M+C reg has good news and bad.
A health plan's cost for terminating a Medi-care+Choice contract [...] - Long-Term Care:
SNFs Win Two Inflation-Related Raises In Medicare Rates
Learn the details to secure your fair share.
There's no time like the present for skilled [...] - HIPAA:
HOSPITALS CALL FOR HIPAA TRANSACTIONS LIFE-LINE
Has CMS done enough to forestall payment disruptions?
Health care providers need more guidance to ensure [...] - Physicians:
HOW PICKING THE WRONG BUSINESS PARTNER CAN COST PROVIDERS BIG
Treating a provider number lightly is a dangerous mistake.
Traffic in Medicare provider numbers has landed [...] - Cost Reporting:
MORE PROVIDERS BRACE FOR ELECTRONIC COST REPORTING
Free software in the works for cash-strapped organizations.
More types of health care providers than ever [...] - DME:
SUPPLIERS IN FOR CPAP SLAP
Coding change for respiratory assist devices could spell trouble.
Durable medical equipment suppliers could face a [...] - Pharmaceuticals:
Medicare Hatches Plans To Slash DME Drug Payments
Trade group warns of access problems if no service component is added.
Durable medical equipment suppliers [...] - Coding:
CCI EDITS FREE ONLINE
At long last, CMS makes the CCI edts available on its Web site. Physicians who've [...] - Pharmaceuticals:
DRUG REBATES STILL RAISING EYEBROWS WITH THE FEDS
States may get more agressive on rebate collections. The HHS Office of Inspector General continues [...] - Pharmaceuticals:
DRUGMAKERS SADDLED WITH PRICE-CHANGE LIMITS
There's good news and bad news for drugmakers in new rules on Medicaid rebates. Drugmakers [...] - Physicians:
MORE REIMBURSEMENT FOR PNEUMOCOCCAL VACCINE
Good news for physicians planning to buy ahead.
Physicians will collect higher Part B payments for [...] - PROGRAM MEMO ROUNDUP
The Centers for Medicare & Medicaid Services has added a trio of new "K" codes [...]
